openPR Logo
Press release

Immunoassay Instruments Market - Global Industry Insights, Trends, and Opportunity Analysis, 2017–2025

10-23-2017 03:51 PM CET | Health & Medicine

Press release from: Medical Devices Market Report

Immunoassay Instruments Market - Global Industry Insights,

Immunoassay Instruments are bioanalytical devices used to perform automated biochemical tests for the detection of various substances or specific proteins in the samples. The immunoassay instruments, also known as analyzers are used in hospitals and clinical laboratories to detect the concentration and presence of analytes in the blood, plasma and urine samples. The immunoassay tests rely on the ability of antibody binding to a specific structure of molecule present in the analytes. The concentration of proteins is measured using the specific antigen-antibody binding properties. The quantification and identification of proteins in the analyte sample is done by using the antibody as a reagent. The advantages of using immunoassay instruments are the minimal human resistance, simultaneous screening of multiple samples. The high sensitivity, reliability, and applicability to a range of compounds, distinctive selective and detection abilities at extremely low concentrations of nanogram to pictogram make immunoassays a powerful tool.

A wide variety to address health problems drives the immunoassay instruments market

According to the Disease Prevention and Health Promotion estimates in 2017, the immunoassay techniques have prevented up to 14 million lives with early diagnosis, reducing the healthcare costs by $9.9 billion. The adoption of automated techniques to test various substances including antibiotic, anticonvulsant or cardiac glycoside drug concentration determination, cancer markers, endocrine hormone testing drives the market. Rising prevalence of infectious diseases with early diagnosis, prevention, and treatment is the main factor boosting the demand for compact consumable products and instruments in the healthcare sector. The launch of various FDA approved innovative products is expected to fuel the commercialization of immunoassay instruments significantly in the forecast period. For instance, the launch of fluorescence scanning portable instrument ichroma II and enzyme-linked immunosorbant assay (ELISA) test cartridge by iStat cardiac Troponin I.

Improved workflow owing to ease and comprehensive technology are the prominent factors estimated to boost the automated immunoassay instrument market

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/942

The global immunoassay instruments market is segmented on the basis of product, application, application, end user and geography.

On the basis of product, the global immunoassay instruments market is segmented into:

Enzyme-linked immunoassay
Radioimmunoassay
Chemiluminescence immunoassay
Immunofluorescence analyzers

On the basis of applications, the global immunoassay instruments market is segmented into:

Endocrinology
Cardiology
Oncology
Autoimmune and infectious disease testing
Others

On the basis of end user, the global immunoassay instruments market is segmented into:

Clinical Laboratories
Hospitals
Others

Asia Pacific is expected to lead the market promoting the utilization of immunoassays with the rise in infectious diseases

Regional segmentation of the immunoassay instruments market by Coherent Market Insights comprises North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. North America is expected to dominate the global market owing to the rising demand for technologically advanced clinical diagnostic analyzers capable to perform multiple immunoassays simultaneously. According to the article published in Genetic Engineering and Biotechnology News (GEN), the market for infectious disease testing in the U.S. is expected to grow from U.S. $168 billion in 2015 to U.S. $209 billion in 2020 owing to the upsurge of infectious diseases. Additionally, the rising grants from the government and the private healthcare agencies, contributing towards the development of technology and commercialization of immunoassay analyzers, thereby raising the market in North America. The immunoassay instruments market is expected to boost in Asia Pacific owing to the rising research activities in microbiology sector, increasing the prevalence of infectious and chronic diseases like cholera, tuberculosis, typhoid, autoimmune diseases and rising government healthcare grants. For instance, China directed immunoassay market at an estimated U.S. $626 million in 2013 and is estimated to reach U.S. $1309 million by 2018.

Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/immunoassay-instruments-market-942

The launch of automated chemiluminescence immunoassay instrument by Abbott to rise the demand of immunoassay instruments

The key players operating the immunoassay market are Siemens, Roche Diagnostics, Abbott Laboratories, Danaher Corporation, and BioMérieux SA. The innovative measures adopted by the leading manufacturers to perform different assays in a short time with minimal operator intervention leads to the rising demand by the manufacturers. For instance, the launch of automated immunoassay instrument working on the principle of chemiluminescence Architect i1000SR by Abbott offers high precision, good performance, and low detection limits. Other key vendors operating the market are Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Siemens Medical Solutions Diagnostics, and Trinity Biotech.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunoassay Instruments Market - Global Industry Insights, Trends, and Opportunity Analysis, 2017–2025 here

News-ID: 781951 • Views:

More Releases from Medical Devices Market Report

Global ENT Disorder Treatment Market to Surpass US$ 10 Billion by 2025
Global ENT Disorder Treatment Market to Surpass US$ 10 Billion by 2025
ENT Disorder Treatment Market – Hear Better, Breathe Better, Live Better ENT also known as otolaryngology is a stream of medical science that deals with disorders associated with ear, nose, and throat. Diseases related to ears, throat, and nose significantly affect the quality of life and could lead to surgeries in few cases such as chronic tonsillitis, ear infections, and severe sinusitis problems as well as cancers of the throat or
Endometrial Ablation Market - Global Industry Insights 2025
Endometrial Ablation Market - Global Industry Insights 2025
Endometrial ablation is process that facilitates the destruction of endometrium or thin layer of the uterine wall, in context to treat abnormal heavy uterine bleeding if not controlled with any means of medication. Endometrial ablation is not recommended in women with disorders of endometrium, endometrial hyperplasia, cancer of uterus, recent pregnancy and certain infections of uterus, as per the American College of Obstetrics and Gynecology (ACOG). Depending on technique and
Blood Collection Devices Market - Global Industry Insights 2025
Blood Collection Devices Market - Global Industry Insights 2025
Blood collection devices plays a crucial role in the patient treatment. For the treatment, blood samples are collected to measure the basic metabolism components such as blood urea nitrogen, sodium, potassium, creatinine, magnesium, chloride, and also used to measure blood glucose and lipid levels. In the recent years, as technology has increased in availability and complexity, the experts in the laboratories are receiving wide range of opportunities and challenges. In
Casting and Splinting Products Market - Global Industry Insights 2025
Casting and Splinting Products Market - Global Industry Insights 2025
Casts and splints are designed to protect and support injured or fractured joints and bones. They help to immobilize broken bones or dislocated joints in place, until fully healed. A cast is the treatment of choice in fractures where a minimal amount of swelling is expected, including fractures that are non-displaced as well as complicated conditions such as Paige’s, wherein a cast is placed after subsided swelling due to initial

All 5 Releases


More Releases for Immunoassay

Insights On Immunoassay Market Outlook - Ken Research
An immunoassay is a biochemical analysis that measures the existence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody or an antigen. Immunoassays in scientific research are typically used in the study of biological systems by tracing different proteins, hormones, and antibodies. In industry, they are used to identify contaminants in food and water, and to monitor specific molecules used during
Bahrain Immunoassay Analyzer Market
Transparent healthcare framework & strict procurement system enables the authorities in gaining the trust of the end-users leading to the growth of the medical devices industry in Bahrain: Ken Research Heavy Government involvement in the industry: Bahrain has been maintaining a basic framework for a transparent, rules-based government procurement system. Bahrain hospitals and clinics, as well as developing specialist treatments, are continuously growing. This has improved the installation of BGA, POC
Bahrain Immunoassay Analyzer Market: Ken Research
The report titled "Bahrain Blood Gas and POC Immunoassay AnalyzerMarket Outlook to 2026-Multiple programs to modernize the Bahraini healthcare sector in future including Health Insurance, Health centers and Primary Care Autonomy" provides a comprehensive analysis of the Diagnostic Equipments used in Hospitals and Independent Labs. Report also covers overview and genesis of the industry, product wise market size in terms of installed base; market segmentation by type of device, type
Immunoassay Market Competitive Dynamics 2027
According to the new research report published by The Insight Partners, titled "Immunoassay Market- Global Analysis and Forecast to 2027". The global immunoassay market is US$ 21,800.0 Mn in 2018 and is predicted to grow at a CAGR of 6.5% during the forecast period 2019 - 2027, to reach US$ 37,987.8 Mn by 2027. Immunoassay Market Report presents a competitive scenario of key Immunoassay Industry players with their market share, sales, revenue
Immunoassay Market: Opportunities and Challenges
The Immunoassay Market is expected to reach 27.15 billion by 2023 from USD 20.19 billion in 2018, at a CAGR of 6.1% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 Will the development of condition-specific biomarkers and tests create opportunities for growth for players in the immunoassay market? Biomarkers have gained significant clinical value and interest in the medical industry, as they are very useful in the screening, diagnosis, and treatment of diseases.
Immunoassay Growth Insights 2019 by Major Key Drivers like biotechnology and pha …
Immunoassay Market Highlights Immunoassay is widely used in significant areas of pharmaceutical analysis which include diagnosis of diseases and in therapeutic drug monitoring. A number of factors such as the increasing prevalence of chronic conditions, growth in the biotechnology and pharmaceutical sector, increasing adoption of rental immunoassay analyzers, rising use of immunoassay in oncology, growing awareness about immunoassay, healthcare insurance coverage for various infectious diseases, unmet medical needs, improving regulatory framework, and